Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

TechCrunch - Sep 23, 2026

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read full article

More News

The Next Discovery

The Next Discovery is equipped with recent Science & Tech news to impart knowledge to individuals awaiting the future.

NEWSLETTER